Science & Technology

(English) DP Quality Control: How to Control Visible Particulates in Injections?2/2

申し訳ありません、このコンテンツはただ今 中文 のみです。 For the sake of viewer convenience, the content is shown below in the alternative language. You may click the link to switch the active language.

(English) DP Quality Control: How to Control Visible Particulates in Injections?1/2

申し訳ありません、このコンテンツはただ今 中文 のみです。 For the sake of viewer convenience, the content is shown below in the alternative language. You may click the link to switch the active language.

(English) A Brief introduction on the Challenges and Strategies in Antibody Drug Production

申し訳ありません、このコンテンツはただ今 Englishと 中文 のみです。 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language. A Brief introduction on the Challenges and Strategies in Antibody Drug Production No content available

(English) Key Points in the Implementation of Biopharmaceutical Technology Transfer

申し訳ありません、このコンテンツはただ今 Englishと 中文 のみです。 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language. Key Points in the Implementation of Biopharmaceutical Technology Transfer No content available

(English) Webinar | Strategies for Characterization and Analysis of Impurities throughout the Life Cycle of Antibody Drugs

申し訳ありません、このコンテンツはただ今 Englishと 中文 のみです。 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language.

(English) CHO Cell Line Development: Process and Key Technical Points Overview

申し訳ありません、このコンテンツはただ今 Englishと 中文 のみです。 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language. CHO Cell Line Development: Process and Key Technical Points Overview No content available

(中文) 生物类似药中美欧法规速递

申し訳ありません、このコンテンツはただ今 中文 のみです。 For the sake of viewer convenience, the content is shown below in the alternative language. You may click the link to switch the active language.

(English) Whitepaper | Immunogenicity of Innovative and Biosimilar Monoclonal Antibodies

申し訳ありません、このコンテンツはただ今 Englishと 中文 のみです。 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language.

categoryidArraymk-test